Taigen Biopharmaceuticals Holdings Ltd (4157) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.040x

Based on the latest financial reports, Taigen Biopharmaceuticals Holdings Ltd (4157) has a cash flow conversion efficiency ratio of -0.040x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-41.33 Million ≈ $-1.30 Million USD) by net assets (NT$1.02 Billion ≈ $32.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Taigen Biopharmaceuticals Holdings Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Taigen Biopharmaceuticals Holdings Ltd - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Taigen Biopharmaceuticals Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Taigen Biopharmaceuticals Holdings Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Taigen Biopharmaceuticals Holdings Ltd ranked by their cash flow conversion efficiency. Explore Taigen Biopharmaceuticals Holdings Ltd (4157) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
AIRO Group Holdings, Inc. Common Stock NASDAQ:AIRO	-0.008x
Superior Uniform Group Inc NASDAQ:SGC	0.049x
CMC Corp VN:CMG	0.060x
Hillgrove Resources Ltd AU:HGO	0.266x
Solvar Ltd AU:SVR	0.099x
NORTHERN OCEAN LTD. F:4JO	-0.091x
Taokaenoi Food & Marketing Public Company Limited BK:TKN	0.148x
Plum Acquisition Corp. IV Class A Ordinary Shares NASDAQ:PLMK	-0.001x

Annual Cash Flow Conversion Efficiency for Taigen Biopharmaceuticals Holdings Ltd (2010–2025)

The table below shows the annual cash flow conversion efficiency of Taigen Biopharmaceuticals Holdings Ltd from 2010 to 2025. View latest Taigen Biopharmaceuticals Holdings Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$1.07 Billion ≈ $33.86 Million	NT$20.93 Million ≈ $659.38K	0.019x	+112.18%
2024-12-31	NT$1.08 Billion ≈ $34.10 Million	NT$-173.09 Million ≈ $-5.45 Million	-0.160x	-962.72%
2023-12-31	NT$1.12 Billion ≈ $35.25 Million	NT$20.74 Million ≈ $653.46K	0.019x	+184.54%
2022-12-31	NT$970.03 Million ≈ $30.56 Million	NT$-21.27 Million ≈ $-670.09K	-0.022x	-104.37%
2021-12-31	NT$1.25 Billion ≈ $39.50 Million	NT$629.07 Million ≈ $19.82 Million	0.502x	+191.65%
2020-12-31	NT$442.18 Million ≈ $13.93 Million	NT$-242.10 Million ≈ $-7.63 Million	-0.548x	-30.30%
2019-12-31	NT$815.18 Million ≈ $25.68 Million	NT$-342.52 Million ≈ $-10.79 Million	-0.420x	-80.21%
2018-12-31	NT$1.09 Billion ≈ $34.45 Million	NT$-254.93 Million ≈ $-8.03 Million	-0.233x	-24.43%
2017-12-31	NT$1.42 Billion ≈ $44.88 Million	NT$-266.93 Million ≈ $-8.41 Million	-0.187x	+17.16%
2016-12-31	NT$675.62 Million ≈ $21.29 Million	NT$-152.83 Million ≈ $-4.82 Million	-0.226x	+83.14%
2015-12-31	NT$441.60 Million ≈ $13.91 Million	NT$-592.56 Million ≈ $-18.67 Million	-1.342x	-111.73%
2014-12-31	NT$852.14 Million ≈ $26.85 Million	NT$-540.03 Million ≈ $-17.01 Million	-0.634x	+78.74%
2013-12-31	NT$153.77 Million ≈ $4.84 Million	NT$-458.46 Million ≈ $-14.44 Million	-2.981x	-686.28%
2012-12-31	NT$372.80 Million ≈ $11.75 Million	NT$-141.36 Million ≈ $-4.45 Million	-0.379x	+48.69%
2011-12-31	NT$513.21 Million ≈ $16.17 Million	NT$-379.23 Million ≈ $-11.95 Million	-0.739x	-1713.58%
2010-12-31	NT$-4.29 Billion ≈ $-135.14 Million	NT$-196.43 Million ≈ $-6.19 Million	0.046x	--

About Taigen Biopharmaceuticals Holdings Ltd

TWO:4157 Taiwan Biotechnology

Market Cap

$198.48 Million

NT$6.30 Billion TWD

Market Cap Rank

#16644 Global

#806 in Taiwan

Share Price

NT$8.85

Change (1 day)

-0.23%

52-Week Range

NT$7.90 - NT$15.60

All Time High

NT$37.39